Abstract
Get full access to this article
View all access options for this article.
References
1.
Mason
PJ
Morris
VA
Balcezak
TJ
. Serotonin syndrome. Presentation of 2 cases and a review of the literature . Medicine 2000 ;79 : 201 –9 .
2.
Karagianis
JL
Phillips
LC
Hogan
KP
LeDrew
KK
. Clozapine-associated neuroleptic malignant syndrome: Two new cases and a review of the literature . Ann Pharmacother 1999 ;33 : 623 –30 .
3.
Caroff
SN
Mann
SC
. Neuroleptic malignant syndrome . Psychopharmacol Bull 1988 ;24 : 25 –9 .
4.
Kline
SS
Mauro
LS
Scala-Barnett
DM
Zick
D
. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death . Clin Pharm 1989 ;8 : 510 –3 .
5.
Christensen
V
Glenthoj
BY
. [Malignant neuroleptic syndrome or serotonergic syndrome.] Danish . Ugeskr Laeger 2001 ;163 : 301 –2 .
6.
Gaston
Lopez OD
Wierzbinsky
S
Gaston
Lopez RS
Resnik
S
Pardomenico
S
Jorge
M
. [Sertraline. Adverse effects due to superposition of serotonic and malignant neuroleptic syndromes.] Spanish . Medicina (B Aries) 2000 ;60 : 241 –4 .
7.
Brennan
D
MacManus
M
Howe
J
McLoughlin
J
. “Neuroleptic malignant syndrome” without neuroleptics (letter) . Br J Psychiatry 1988 ;152 : 578 –9 .
8.
Fink
M
. Toxic serotonin syndrome or neuroleptic malignant syndrome . Pharmacopsychiatry 1996 ;29 : 159 –61 .